Top Markets
Coin of the day
SymBio Pharmaceuticals Limited SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals Limited

4582
Rank in Stocks #28752
SymBio Pharmaceuticals Limited engages in the and development, manufacturing... SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
Share Price
$0.45018154
Market Cap
$24.81M
Change (1 day)
1.47%
Change (1 year)
-56.57%
Country
JP
Trade SymBio Pharmaceuticals Limited (4582)

Category

P/B ratio for SymBio Pharmaceuticals Limited (4582)
P/B ratio as of 2026 TTM: 0
According to SymBio Pharmaceuticals Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for SymBio Pharmaceuticals Limited from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors